Michael T. Reynolds represents a broad range of public and private companies as well as non‑profit organizations in complex civil litigation and internal investigations relating to securities, antitrust, contract, copyright, the False Claims Act, the Foreign Corrupt Practices Act and compliance with federal and international laws and regulations.
Reynolds regularly coordinates national litigation defense strategies for major corporations in business-critical litigation, including in the pharmaceutical, chemical and energy industries. He is currently serving as national resolution counsel for a global healthcare company in a major mass tort matter, providing high‑level strategic litigation advice and coordinating the company’s resolution strategy. Reynolds also serves as national resolution counsel to a chemical company in connection with litigation and regulatory inquiries in a significant mass tort matter.
Reynolds also focuses on high-profile investigations involving civil, regulatory and criminal allegations across multiple industries. His representative matters include conducting an investigation for a major media company, as well as representing a multinational European company in connection with multiple investigations involving a variety of government entities.
Lawdragon Honors
Reynolds has represented major financial institutions in a variety of matters. As lead counsel in over 50 residential mortgage‑backed securities lawsuits around the country for one client, he eliminated approximately $14.3 billion in claims and helped obtain a landmark decision concerning the statute of limitations for cases under New York’s Martin Act. He also successfully represented two banks in contract and tort actions in state court in Delaware, New York and Texas arising from a failed multibillion‑dollar merger and secured the dismissal of a Fortune 20 bank from a securities fraud suit concerning collateral debt obligations. He recently secured for a major bank the dismissal of breach of contract and fraud claims relating to the financing of a substantial acquisition.
Reynolds has also handled high‑profile antitrust litigation. He secured a $750 million settlement for a major technology company in a suit concerning internet operating systems and represented another technology company in litigation alleging monopolization of markets for computer hardware, which was dismissed. Reynolds also helped obtain a summary judgment victory for a medical device company in antitrust litigation concerning catheters used in cardiac mapping.
Among his other matters, Reynolds secured for one baseball team the dismissal of a consolidated purported class action relating to alleged electronic sign stealing brought by daily fantasy sports contest participants, which was affirmed on appeal; obtained a favorable settlement for a solar panel manufacturer in a securities class action relating to solar modules; was part of the trial team that obtained judgments in favor of an acclaimed entertainment company in copyright and trademark litigation; obtained summary judgment in favor of a major entertainment company in a breach of contract dispute over the broadcasting of certain films; and obtained a precedent‑setting ruling on behalf of two pharmaceutical companies in qui tam litigation over alleged pricing misrepresentations.